|The C1QTNF4 c1qtnf4 (Catalog #MBS613810) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The CTRP4, CT (C1q Tumor Necrosis Factor alpha Related Protein 4) reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s CTRP4 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
Suitable for use in Western Blot.
Dilution: Western Blot: 1-2ug/ml. Researchers should empirically determine the suitability of the C1QTNF4 c1qtnf4 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The C1QTNF4 c1qtnf4 product has the following accession number(s) (GI #148233912) (NCBI Accession #NP_114115.2) (Uniprot Accession #Q9BXJ3). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Adipose tissue of an organism plays a major role in regulating physiologic and pathologic processes such as metabolism and immunity by producing and secreting a.
Immunogen: Synthetic peptide CTRP4,16aa near the carboxy terminus of human CTRP4 (Genbank accession No. AAH35628). Positive Control: Rat brain cell lysate. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing C1QTNF4 are readily searchable from our website. Different antibodies against the same target such as C1QTNF4 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.